Profile data is unavailable for this security.
About the company
Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
- Revenue in SEK (TTM)174.14m
- Net income in SEK-57.24m
- Incorporated2004
- Employees78.00
- LocationSedana Medical AB (publ)Vendevagen 89DANDERYD 182 32SwedenSWE
- Phone+46 812405200
- Fax+46 812405296
- Websitehttps://sedanamedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mentice AB | 274.55m | -23.28m | 641.78m | 130.00 | -- | 4.63 | 205.96 | 2.34 | -0.9104 | -0.9104 | 10.71 | 5.42 | 0.9243 | 2.77 | 4.38 | 2,250,394.00 | -7.84 | -7.69 | -15.21 | -13.07 | 85.89 | 83.67 | -8.48 | -10.00 | 0.9251 | -- | 0.0285 | -- | 25.54 | 11.74 | 90.81 | -- | -10.83 | -- |
| Gentian Diagnostics ASA | 144.63m | 2.19m | 661.90m | 58.00 | 345.40 | 4.16 | 59.27 | 4.58 | 0.1262 | 0.1262 | 9.35 | 10.47 | 0.7792 | 1.69 | 8.40 | 2,533,190.00 | 1.18 | -10.76 | 1.33 | -11.86 | 51.69 | 41.46 | 1.51 | -26.99 | 5.01 | -- | 0.0394 | -- | 32.98 | 27.63 | 54.92 | -- | -4.92 | -- |
| Senzime AB (publ) | 55.29m | -131.46m | 691.35m | 52.00 | -- | 2.56 | -- | 12.50 | -1.09 | -1.09 | 0.4595 | 2.38 | 0.1533 | 1.57 | 4.91 | -- | -36.44 | -35.69 | -39.12 | -38.00 | 33.27 | -20.59 | -237.75 | -558.68 | 2.62 | -- | 0.0739 | -- | 154.77 | 61.90 | -1.09 | -- | -3.69 | -- |
| OssDsign AB | 123.46m | -113.80m | 703.14m | 27.00 | -- | 3.13 | -- | 5.70 | -1.40 | -1.40 | 1.43 | 2.30 | 0.4311 | 2.50 | 6.80 | 2,572,083.00 | -39.74 | -37.92 | -43.39 | -43.56 | 83.94 | 68.10 | -92.18 | -203.06 | 5.92 | -21.65 | 0.0114 | -- | 96.84 | 53.26 | -31.30 | -- | -56.16 | -- |
| ADDvise Group AB (publ) | 1.63bn | 114.40m | 768.33m | 643.00 | 20.22 | 3.05 | 3.65 | 0.4724 | 0.5935 | 0.5935 | 8.38 | 3.93 | 0.565 | 8.37 | 5.77 | 2,606,250.00 | 3.98 | 3.72 | 4.82 | 4.77 | 42.07 | 48.95 | 7.04 | 5.89 | 1.40 | 2.35 | 0.6969 | 0.9405 | 44.30 | 38.62 | 27.62 | -- | 30.35 | -- |
| C Rad AB | 497.02m | 53.43m | 941.06m | 94.00 | 18.07 | 3.19 | 15.04 | 1.89 | 1.58 | 1.58 | 14.72 | 8.96 | 1.23 | 5.04 | 2.72 | 5,712,816.00 | 13.25 | 5.09 | 19.16 | 7.02 | 46.30 | 43.12 | 10.81 | 4.86 | 2.32 | -- | 0.0049 | 0.00 | 40.92 | 17.44 | 375.05 | 10.89 | 33.69 | -- |
| Optomed Oyj | 157.46m | -69.35m | 1.03bn | 113.00 | -- | 3.60 | -- | 6.55 | -0.3355 | -0.3355 | 0.763 | 1.26 | 0.4267 | 1.75 | 4.06 | 119,307.00 | -18.79 | -12.95 | -22.82 | -15.90 | 64.80 | 65.69 | -44.04 | -27.84 | 2.76 | -20.42 | 0.1313 | -- | 3.00 | 3.47 | 18.84 | -- | 7.26 | -- |
| Bactiguard Holding AB | 254.96m | -56.11m | 1.11bn | 163.00 | -- | 3.83 | -- | 4.37 | -1.60 | -1.60 | 7.28 | 9.37 | 0.3706 | 3.84 | 7.60 | 1,174,917.00 | -8.16 | -7.56 | -11.32 | -8.81 | 47.53 | 47.91 | -22.01 | -26.28 | 0.5898 | -2.72 | 0.4175 | -- | -11.96 | 6.46 | -161.71 | -- | 8.43 | -- |
| BioPorto A/S | 52.50m | -77.62m | 1.19bn | 33.00 | -- | 7.31 | -- | 22.66 | -0.1397 | -0.1397 | 0.0941 | 0.244 | 0.2777 | 3.23 | 9.02 | 1,091,290.00 | -41.06 | -71.10 | -51.28 | -96.55 | 71.13 | 63.38 | -147.84 | -239.22 | 5.16 | -- | 0.0517 | -- | 6.87 | 3.54 | 25.81 | -- | -51.56 | -- |
| Sedana Medical AB (publ) | 174.14m | -57.24m | 1.19bn | 78.00 | -- | 1.25 | -- | 6.85 | -0.5763 | -0.5763 | 1.75 | 9.56 | 0.1697 | 1.16 | 10.14 | 2,204,317.00 | -5.58 | -5.77 | -5.84 | -6.08 | 70.60 | 64.06 | -32.87 | -36.13 | 6.02 | -30.48 | 0.0076 | -- | 25.23 | 21.59 | 18.90 | -- | 42.12 | -- |
| Paxman AB (publ) | 238.86m | 28.64m | 1.34bn | 102.00 | 46.83 | 9.18 | 28.51 | 5.60 | 1.50 | 1.50 | 12.54 | 7.67 | 1.31 | 2.74 | 6.56 | 2,624,791.00 | 15.66 | -5.08 | 20.74 | -7.76 | 70.27 | 69.38 | 11.99 | -5.07 | 1.98 | 12.73 | 0.0838 | -- | 43.99 | 29.35 | 180.69 | -- | 6.26 | -- |
| Nordhealth As | 477.64m | -107.92m | 1.69bn | 355.00 | -- | 3.26 | 100.08 | 3.53 | -1.41 | -1.41 | 6.20 | 11.63 | 0.4329 | -- | 6.73 | 1,228,425.00 | -9.78 | -- | -11.11 | -- | 85.82 | -- | -22.59 | -- | -- | -- | 0.00 | -- | 18.60 | -- | 21.96 | -- | -- | -- |
| Genovis AB | 129.73m | 27.91m | 1.75bn | 32.00 | 62.86 | 7.90 | 44.79 | 13.52 | 0.4263 | 0.4263 | 1.98 | 3.39 | 0.4239 | -- | -- | 3,506,189.00 | 9.12 | 18.56 | 9.80 | 21.45 | 64.69 | 65.51 | 21.51 | 23.88 | -- | -- | 0.2555 | 0.00 | 54.54 | 35.56 | 449.56 | -- | 47.59 | -- |
Data as of Nov 13 2024. Currency figures normalised to Sedana Medical AB (publ)'s reporting currency: Swedish Krona SEK
36.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Swedbank Robur Fonder ABas of 30 Sep 2024 | 7.97m | 8.02% |
| E. �hman J :or Fonder ABas of 31 May 2024 | 6.93m | 6.98% |
| Handelsbanken Fonder ABas of 31 Oct 2024 | 4.15m | 4.18% |
| Premier Fund Managers Ltd.as of 28 Jun 2024 | 3.68m | 3.71% |
| Highclere International Investors LLPas of 31 May 2024 | 3.31m | 3.33% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 29 Sep 2023 | 3.05m | 3.07% |
| AMF Fonder ABas of 31 May 2024 | 2.49m | 2.51% |
| Amundi Asset Management SA (Investment Management)as of 30 Aug 2024 | 1.90m | 1.91% |
| Tredje AP-fondenas of 31 Dec 2023 | 1.74m | 1.75% |
| AXA Investment Managers (Paris) SAas of 31 Jul 2024 | 1.32m | 1.33% |
More ▼
Data from 30 Jun 2024 - 06 Nov 2024Source: FactSet Research Systems Inc.
